Not recruitingISRCTN82596506
The Incredible Years Ireland study
This study isn't currently recruiting.
In IrelandADHDResearch studyAges 3–6
ADHD studies
ADHD
Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.
Not recruitingISRCTN93932965
Understanding sensory experiences of neurodiverse adolescents in mainstream secondary schools
This study isn't currently recruiting.
In United KingdomADHDResearch studyAges 10–19
CompletedNCT00598182
Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study
Official study title
From Immediate-release MPH to OROS MPH: The Impact Upon Family of Children and Adolescents With ADHD
This study has finished and is no longer accepting participants.
In TaipeiADHDObservational study
CompletedACTRN12616001332415
NeuroFeedback to treat young people with ADHD and Tics.
Official study title
Neurofeedback as a non-pharmacological and non-invasive alternative to treat young patients with ADHD and co-morbid tic symptoms – A pilot study in a community setting.
This study has finished and is no longer accepting participants.
In AustraliaADHDInterventional studyAges 8–16
CompletedEUCTR 2011-000210-19
A 6-month, open-label extension to a 40-week, randomized, double-blind, placebo-controlled, multicenter efficacy and safety study of Ritalin® LA in the treatment of adult patients with childhood-on...
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BelgiumADHDHistorical research record
CompletedEUCTR 2005-003002-28
A 7 week multicenter, double-blind, randomized, placebo-controlled cross-over evaluation of the efficacy and safety of a modified-release oral dosage form of methylphenidate-HCl, Ritalin LA® (20 mg...
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanyADHDHistorical research record
CompletedEUCTR 2007-002111-82
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate Efficacy and Safety of Prolonged Release (PR) OROS® methylphenidate (54 and 72 mg/day) i...
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BelgiumADHDHistorical research record
CompletedEUCTR 2004-000730-37
A multicentre, randomised, double-blind, placebo-controlled, parallel group, dose-response phase III A study to evaluate safety and efficacy of Prolonged Release (PR) OROS methylphenidate (18, 36 a...
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In Czech RepublicADHDHistorical research record
CompletedEUCTR 2009-011745-94
A Phase 3b, Double-blind, Randomised, Active-controlled, Parallel-group Study to Compare the Time to Response of Lisdexamfetamine Dimesylate to Atomoxetine Hydrochloride in Children and Adolescents...
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BelgiumADHDHistorical research record
CompletedEUCTR 2008-000720-10
A Phase III, Double- Blind, Placebo- Controlled, Randomised Withdrawal, Multicentre, Extension, Safety and Efficacy of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17 with A...
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BelgiumADHDHistorical research record
CompletedEUCTR 2008-000679-90
A Phase III, Randomised, Double-Blind, Multicentre, Parallel-Group, Placebo- and Active-Controlled, Dose-Optimisation Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and ...
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BelgiumADHDHistorical research record
CompletedEUCTR 2004-004088-31
A Randomized Double-Blind, Placebo-Controlled Clinical Trial of Efficacy and Safety of Atomoxetine up to 12 weeks in Newly Diagnosed Children and Adolescents Outpatients with Attention-Deficit/Hyp...
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In SpainADHDHistorical research record
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.